Unraveling Unexpected Palladium Catalyst Poisoning by Liquid Chromatography–Mass Spectrometry

Abstract Palladium-catalyzed cross-coupling reactions are cornerstones of drug manufacturing during pharmaceutical development. However, their efficiencies can be susceptible to trace levels of “catalyst poisons”, particularly at low palladium loadings. These poisons decimate reactions, yet identifying them is often a daunting ghost hunt. This challenge was recently exemplified during a kilogram-scale demo campaign, where reaction conversion dropped from near 100% to less than 10%, following a slightly revised cysteine wash procedure inserted to control palladium levels in a previous step. While standard analytical assays cleared known scavengers such as cysteine, the subsequent cross-coupling reaction remained inhibited. By comparing the intermediates and final reaction products via a suite of liquid chromatography–mass spectrometry (LC-MS) experiments utilizing both discovery and targeted analyses, we uncovered the unexpected derivatization of cysteine with starting materials and a Smiles rearrangement as the culprits. Finally, we developed a fluorescence-based free-thiol assay to rapidly quantify cysteine derivatives during redevelopment of the washing procedure. These data led to an updated process that fully purged free thiols, ultimately restoring the reactivity and conversion. The study highlights the power of LC-MS beyond standard quality controls to guide development and solve unexpected and complex manufacturing failures.